Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSphere Medical Holding Regulatory News (SPHR)

  • There is currently no data for SPHR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

£3 Million Loan Facility

4 Jan 2017 07:00

RNS Number : 2490T
Sphere Medical Holding plc
04 January 2017
 

4 January 2017

 

Sphere Medical Holding plc

("Sphere", "Sphere Medical" or the "Company")

£3 Million Loan Facility

 

Sphere Medical Holding plc (AIM: SPHR.L), an innovative point-of-care monitoring and diagnostic devices company, is pleased to announce that it has secured a £3 million loan facility (the "Facility") from Silicon Valley Bank.

 

Under the Facility, an initial loan of £1.5m is being drawn immediately. A further £1.5m loan will be conditionally available until March 2018. The funding from the Facility will be used for general corporate purposes. The loans will be repayable by March 2020.

 

Richard Wright, the Company's Chief Financial Officer, commented: "Now that we have launched Proxima 4, this additional funding gives us important extra flexibility as we advance through the launch phase. We welcome the support from Silicon Valley Bank which is a further demonstration of the continuing commercialisation of the Company."

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

- Ends -

 

For further information, please contact:

 

Sphere Medical Holding plc

Tel: +44 (0)1223 875 222

Dr Wolfgang Rencken, Chief Executive Officer

Richard Wright, Chief Financial Officer

Panmure Gordon

Tel: +44 (0) 20 7886 2500

Freddy Crossley (Corporate Finance)

Duncan Monteith (Corporate Finance)

Tom Salvesen (Corporate Broking)

Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott

spheremedical@consilium-comms.com

Ivar Milligan

Hendrik Thys

 

 

Notes for Editors

 

About Sphere Medical (AIM: SPHR.L)

 

Sphere Medical is an innovative point-of-care medical device company. Its Proxima platform measures blood gases, electrolytes and metabolites at the patient's bedside and aims to improve patient care and reduce health system costs. The device is sold directly to the critical care market via Sphere Medical's sales force in the UK, Germany, The Netherlands and Belgium and via distributors in Italy and Spain. For further information, please visit www.spheremedical.com.

 

About Silicon Valley Bank UK

 

For more than 30 years, Silicon Valley Bank (SVB) has helped innovative businesses, enterprises and their investors move bold ideas forward, fast. SVB provides a range of targeted financial services and expertise through its office in the UK. With commercial and international banking services, SVB helps address the unique needs of innovators. The UK's leading technology and life science businesses, in all stages of development, look to SVB's niche expertise, 30 years of experience and unparalleled network, as they grow at home and tackle new markets abroad.

Learn more at svb.com/uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDSSSFWDFWSEEF
Date   Source Headline
18th Jul 201311:17 amRNSTR-1: Notification of Major Interest in Shares
17th Jul 20135:20 pmRNSTR-1: Notification of Major Interest in Shares
17th Jul 20134:36 pmRNSTR-1: Notification of Major Interest in Shares
17th Jul 20133:14 pmRNSTR-1: Notification of Major Interest in Shares
17th Jul 20138:01 amRNSDirector/PDMR Shareholding
16th Jul 201312:00 pmRNSResult of General Meeting
16th Jul 20137:00 amRNSResult of Open Offer
8th Jul 20137:00 amRNSPositive results from Proxima technology
1st Jul 20137:00 amRNSPosting of Shareholder Circular
28th Jun 20134:08 pmRNS2012 Annual Report & Accounts and Notice of AGM
28th Jun 20131:13 pmRNSFinal Results for the year ended 31 December 2012
28th Jun 20131:04 pmRNSProposed Collaboration Agreement and Fundraising
4th Dec 20122:40 pmRNSTR-1: Notification of Major Interest in Shares
23rd Nov 20127:00 amRNSPositive Results from Pelorus 1500 Study
25th Sep 20129:30 amRNSPresenting at Proactive Investors Investor Forum
20th Sep 20127:00 amRNSInterim Results 2012
29th Aug 20127:00 amRNSNotice of Interim Results
16th Jul 20127:00 amRNSPelorus 1500 IVD Achieves CE Marking
10th Jul 20127:00 amRNSFirst Sales Order from Sorin for CPB Product
21st Jun 20127:00 amRNSSphere Appoints Distributor in Japan
29th May 20122:29 pmRNSResult of Annual General Meeting
21st May 20127:00 amRNSGrant of Options and Directors' Interests
21st May 20127:00 amRNSGrant of Share Options and Directors' Interests
8th May 20127:00 amRNS2011 Annual Report & Accounts and Notice of AGM
22nd Mar 20127:00 amRNSPreliminary Results
24th Feb 20127:00 amRNSNotice of Preliminary Results
8th Feb 20127:00 amRNSImproving Accuracy of Propofol Dosing
5th Jan 20121:13 pmRNSAmended Notice of Interest in Shares
19th Dec 20117:00 amRNSProxima Generation 2 Achieves European CE Marking
13th Dec 20113:51 pmRNSNotification of Major Interest in Shares
23rd Nov 20117:00 amRNSScope Extension to include Manufacturing
22nd Nov 20113:10 pmRNSNotice of Interest in Shares
21st Nov 201112:49 pmRNSNotice of Interest in Shares
21st Nov 20117:00 amRNSNotification of Major Interest in Shares
21st Nov 20117:00 amRNSClinical Trial Success
18th Nov 20118:40 amRNSCompleted Second Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.